AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

 11,870.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 15,316.00
  • 52 Week Low: 11,460.00
  • Currency: UK Pounds
  • Shares Issued: 1,551.05m
  • Volume: 0
  • Market Cap: £184,110m
  • RiskGrade: 123
  • Beta: 0.00

Latest Deals

Traded Action Notifier PriceAmountValue
14-Sep-26 Buy Pascal Soriot 12,102.00p 60,000 £7,261,199.80
14-Sep-26 Buy Dividends Aradhana Sarin 0.000p 73 £0.00
14-Sep-26 Buy Michel Demare 12,121.33p 2,500 £303,033.24

Largest Deals (28 days)

Traded Action Notifier PriceAmountValue
14-Sep-26 Buy Pascal Soriot 12,102.00p 60,000 £7,261,199.80
14-Sep-26 Buy Michel Demare 12,121.33p 2,500 £303,033.24
14-Sep-26 Buy Dividends Aradhana Sarin 0.000p 73 £0.00

Director Shareholdings

Notifier Holding Value*
Pascal Soriot 941,175 £111,717,472
Aradhana Sarin 121,006 £14,363,412
Marcus Wallenberg 60,028 £7,125,324
Philip A J Broadley 19,495 £2,314,056
Michel Demare 12,500 £1,483,750
Tony Mok 3,500 £415,450
Sheri McCoy 1,736 £206,063
Karen Knudsen 1,405 £166,774
Diana Layfield 1,400 £166,180
Euan Ashley 1,150 £136,505
Anna Manz 487 £57,807

Major Shareholders

Notifier** Holding Value*
BlackRock, Inc 100,885,181 £11,975,070,985
Oddo Meriten Asset Management SA 100,885,181 £11,975,070,985
The Capital Group Companies, Inc. 77,125,348 £9,154,778,808
Wellington Management Company LLP 65,118,411 £7,729,555,386
Investor AB 51,587,810 £6,123,473,047

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 11,870.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 15,316.00
52 Week Low 11,460.00
Volume 0
Shares Issued 1,551.05m
Market Cap £184,110m
Beta 0.00
RiskGrade 123

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
95.58% below the market average95.58% below the market average95.58% below the market average95.58% below the market average95.58% below the market average
84.21% below the sector average84.21% below the sector average84.21% below the sector average84.21% below the sector average84.21% below the sector average
Price Trend
11.74% above the market average11.74% above the market average11.74% above the market average11.74% above the market average11.74% above the market average
48.84% above the sector average48.84% above the sector average48.84% above the sector average48.84% above the sector average48.84% above the sector average
Income
73.37% below the market average73.37% below the market average73.37% below the market average73.37% below the market average73.37% below the market average
Sector averageSector averageSector averageSector averageSector average
Growth
86.76% above the market average86.76% above the market average86.76% above the market average86.76% above the market average86.76% above the market average
71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average

What The Brokers Say

Strong Buy 10
Buy 8
Neutral 5
Sell 0
Strong Sell 0
Total 23
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  1st Interim 2nd Interim
Ex-Div 06-Aug-26 19-Feb-26
Paid 08-Sep-26 23-Mar-26
Amount 106.00¢ 217.00¢

Trades for --2026

Time Volume / Share Price
0 @ 0.000p

AstraZeneca Key Personnel

Chair Michel Demare

Top of Page